GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Formosa Laboratories Inc (TPE:4746) » Definitions » Debt-to-Asset

Formosa Laboratories (TPE:4746) Debt-to-Asset : 0.28 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Formosa Laboratories Debt-to-Asset?

Formosa Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$1,148 Mil. Formosa Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$2,752 Mil. Formosa Laboratories's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was NT$13,895 Mil. Formosa Laboratories's debt to asset for the quarter that ended in Dec. 2024 was 0.28.


Formosa Laboratories Debt-to-Asset Historical Data

The historical data trend for Formosa Laboratories's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formosa Laboratories Debt-to-Asset Chart

Formosa Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.29 0.30 0.30 0.28

Formosa Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.29 0.28 0.28 0.28

Competitive Comparison of Formosa Laboratories's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Formosa Laboratories's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formosa Laboratories's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Formosa Laboratories's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Formosa Laboratories's Debt-to-Asset falls into.


;
;

Formosa Laboratories Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Formosa Laboratories's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(1148.109 + 2752.16) / 13895.381
=0.28

Formosa Laboratories's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(1148.109 + 2752.16) / 13895.381
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Formosa Laboratories  (TPE:4746) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Formosa Laboratories Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Formosa Laboratories's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Formosa Laboratories Business Description

Traded in Other Exchanges
N/A
Address
No. 36-1, Hoping Street, Louchu, Taoyuan, TWN, 33842
Formosa Laboratories Inc is mainly engaged in the wholesale and manufacturing of active pharmaceutical ingredients, as well as ultraviolet absorbers. The company geographically operates in India, Taiwan, Netherlands, Switzerland, Germany, Japan, China, Canada, United States, Spain and Others.

Formosa Laboratories Headlines

No Headlines